Low expression of NQO1 predicts pathological complete response to neoadjuvant chemotherapy in breast cancer patients treated with TAC regimen.

Folia biologica

Volumn 58, Issue 5, 2012, Pages 185-192

  Grim, J ^a   Jandik P ^b   Slanska I ^b   Dolezalova Brcakova E ^b   Fuksa, L ^b   Ryska A ^b   Knizek J ^b   Petera, J ^b   Micuda S ^b   Hornychova H ^b  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NQO1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TUMOR ANTIGEN;

ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; TREATMENT OUTCOME;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NAD(P)H DEHYDROGENASE (QUINONE); NEOADJUVANT THERAPY; TREATMENT OUTCOME;

EID: 84875925292     PISSN: 00155500     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)